Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mack Gene
Gain Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Mack Gene
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Riley Jeffrey Scott
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fuggetta Gianluca
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RICHMAN ERIC I
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Islam Khalid
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Riley Jeffrey Scott
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDSTEIN DOV A MD
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Melincoff Gwen A
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HASLER HANS PETER
Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Ballantyne Charles Evan
Gain Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Ballantyne Charles Evan
No Data